Prevalence of COVID-19 Infection Among HCW in a French University Hospital

Sars-CoV2 Clinical Trial

— EXPOCOVIA  

Official title:

Prevalence of SARS-Cov2 Infection Among HCW in Lille University Hospital

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04371692
• Other study ID #: 2020_35
• Secondary ID: 2020-A00951-38
• Status: Completed
• Start date: June 15, 2020
• Est. completion date: July 9, 2020

Study information

• Verified date: April 2021
• Source: University Hospital, Lille
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The objective of this study is to determine the prevalence of SARS-Cov2 infection among health care workers exposed of Lille University Hospital, to describe its evolution during the epidemic taking into account the influence of occupational and environmental exposure determinants.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 900
• Est. completion date: July 9, 2020
• Est. primary completion date: July 9, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Health Care workers with or without symptoms suggestive of a COVID-19 infection

Exclusion Criteria:

• HCW working off-site at the CHU de Lille
• HCW on sick leave.
• HCW outside the Lille University Hospital temporarily coming as reinforcements in the context of the epidemic.

Related Conditions & MeSH terms

• Infection
• Sars-CoV2

Intervention

Other:
• self-administered questionnaire
Every weeks during 2 months, clinical and occupational questionnaire are performed among a cohort of HCW exposed to covid occupational exposure

Diagnostic Test:
• SARS-Cov2 testing
Every weeks during 2 month, SARS-Cov2 RT-PCR, serological testing are performed among a cohort of HCW exposed to covid occupational exposure

Locations

Country	Name	City	State
France	Hop Claude Huriez Chu Lille	Lille

Sponsors (2)

Lead Sponsor	Collaborator
University Hospital, Lille	Fondation Santé Roquette

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	the prevalence of SARS- Cov2 infection Health Care Worker with or without symptoms suggestive of a COVID-19 infection		at 2 months
Secondary	the prevalence of SARS- Cov2 infection Health Care Worker with or without symptoms suggestive of a COVID-19 infection		once week during 2 months
Secondary	Occupational exposures associated with the SARS-Cov2 infection		once week during 2 months
Secondary	Environmental exposures associated with the SARS-Cov2 infection		once week during 2 months
Secondary	immunologic status of health Care Worker		once week during 2 months
Secondary	inflammatory biomarkers status of Health Care Worker		once week during 2 months